{"disease":{"id":"mild-alzheimer-s-disease","name":"mild alzheimer s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03653156","title":"China Cognition and Aging Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT04701177","title":"Digitally-enhanced, Decentralized, Multi-omics Observational Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Greece 2021 Committee","has_results":false},{"nct_id":"NCT06058234","title":"Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study","phase":"","overall_status":"RECRUITING","enrollment_count":8680,"lead_sponsor_name":"Centers for Medicare and Medicaid Services/ Coverage and Analysis Group","has_results":false},{"nct_id":"NCT01931566","title":"Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3494,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT07016178","title":"Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research","phase":"NA","overall_status":"COMPLETED","enrollment_count":3454,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT01953601","title":"Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1454,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06120361","title":"The Swedish BioFINDER - Primary Care Study","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Skane University Hospital","has_results":false},{"nct_id":"NCT06122415","title":"The Swedish BioFINDER - Memory Clinic Study","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Skane University Hospital","has_results":false},{"nct_id":"NCT01231971","title":"Alzheimer's Disease Neuroimaging Initiative 2","phase":"","overall_status":"COMPLETED","enrollment_count":1182,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02854033","title":"Alzheimer's Disease Neuroimaging Initiative 3","phase":"","overall_status":"COMPLETED","enrollment_count":1141,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT07214974","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Noah Tech, Corp.","has_results":false},{"nct_id":"NCT06793735","title":"Effectiveness of TeleVR App in Cognitive Decline and MCI Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"IRCCS Centro Neurolesi Bonino Pulejo","has_results":false},{"nct_id":"NCT05399888","title":"A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":416,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT07422857","title":"Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":316,"lead_sponsor_name":"JYAMS PET Research & Development Limited","has_results":false},{"nct_id":"NCT06182085","title":"Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":304,"lead_sponsor_name":"PRInnovation GmbH","has_results":false},{"nct_id":"NCT03069014","title":"Study of LM11A-31-BHS in Mild-moderate AD Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"PharmatrophiX Inc.","has_results":false},{"nct_id":"NCT01767909","title":"The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT05542953","title":"[18F]APN-1607 PET in Subjects With AD Compared to HC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"APRINOIA Therapeutics","has_results":false},{"nct_id":"NCT03625622","title":"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"AriBio Co., Ltd.","has_results":false},{"nct_id":"NCT05122598","title":"Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT07294586","title":"Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT05189210","title":"GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"GemVax & Kael","has_results":false},{"nct_id":"NCT05619692","title":"A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03486938","title":"Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"AgeneBio","has_results":true},{"nct_id":"NCT03507790","title":"A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Cognition Therapeutics","has_results":true},{"nct_id":"NCT05417555","title":"Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06843824","title":"A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Institute of Psychology, Chinese Academy of Sciences","has_results":false},{"nct_id":"NCT03538522","title":"A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT06883461","title":"Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Shanghai 10th People's Hospital","has_results":false},{"nct_id":"NCT02703636","title":"NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07027072","title":"Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":114,"lead_sponsor_name":"NeuroBiogen Co., Ltd","has_results":false},{"nct_id":"NCT04983368","title":"A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Actinogen Medical","has_results":false},{"nct_id":"NCT02155946","title":"Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT06934720","title":"VR-based Physical Activity and Reminiscence Therapy","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Hong Kong University of Science and Technology","has_results":false},{"nct_id":"NCT03503669","title":"Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT06792877","title":"Mindfulness for Cognition in Early-stage Alzheimer's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"VA Boston Healthcare System","has_results":false},{"nct_id":"NCT05754021","title":"A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT03462121","title":"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Regenera Pharma Ltd","has_results":false},{"nct_id":"NCT03234686","title":"Deferiprone to Delay Dementia (The 3D Study)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Neuroscience Trials Australia","has_results":false},{"nct_id":"NCT06008639","title":"Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Danyang Huichuang Medical Equipment Co., Ltd.","has_results":false},{"nct_id":"NCT02036645","title":"SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04073628","title":"The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT06221202","title":"Stories in the Moment: Dance Program for People Living With Dementia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":72,"lead_sponsor_name":"DanceStream Projects","has_results":false},{"nct_id":"NCT06548191","title":"TREAD: Time Restricted Eating Intervention for Alzheimer's Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT06618807","title":"Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT05233774","title":"Lomecel-B Effects on Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Longeveron Inc.","has_results":false},{"nct_id":"NCT06668610","title":"A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT02503501","title":"Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":49,"lead_sponsor_name":"HealthPartners Institute","has_results":true},{"nct_id":"NCT05591027","title":"Safety and Target Engagement of Centella Asiatica in Cognitive Impairment","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT05582941","title":"Biomarkers of Cognitive Impairment in Blood Cells","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"University of the Balearic Islands","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}